Why a group of experts rejected MDMA as a PTSD treatment

Here & Now‘s Deepa Fernandes talks with STAT investigative reporter Olivia Goldhill about her reporting on problems plaguing Lykos, the company testing MDMA as a treatment for post-traumatic stress disorder. That company’s work was roundly rejected by a panel of experts advising the Food and Drug Administration.

This article was originally published on WBUR.org.